Author

G. Ahlenstiel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:flow cytometry· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Abayasingam· 1 shared A. Adhikari· 1 shared A. J. Morgan· 1 shared A. J. Potter· 1 shared A. Maczurek· 1 shared A. R. Lloyd· 1 shared A. Terry· 1 shared A. W. Bartlett· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Abayasingam

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Longitudinal characterisation of phagocytic and neutralisation functions of anti-Spike antibodies in plasma of patients after SARS-CoV-2 infection.

A. Adhikari, A. Abayasingam, C. Rodrigo, D. Agapiou, E. Pandzic, N. A. Brasher, B. S. M. Fernando, E. Keoshkerian, H. Li, H. N. Kim, M. Lord, G. Popovic, W. Rawlinson, M. Mina, J. J. Post, , N. Tedla

This study shows that phagocytic and neutralisation functions of anti-Spike antibodies persist in SARS-CoV-2 convalescents despite declining antibody titers, with improved antibody affinity correlating with maintained effector functions.

bioRxiv · Dec 21, 2021 · PreprintImmunology

The Role of CD147 in Leukocyte Aggregation in Liver Injury

N. Main, C. Yee, A. Terry, I. Stevanovski, A. Maczurek, A. J. Morgan, S. Calabro, A. J. Potter, T. L. Iemma, D. G. Bowen, G. Ahlenstiel, F. J. Warner, G. W. McCaughan, S. V. McLennan, N. A. Shackel

This study identifies CD147 as a mediator of leukocyte aggregation in liver injury, showing that blocking CD147 reduces aggregate formation and liver damage without affecting overall leukocyte numbers.

bioRxiv · Apr 6, 2019Immunology